Two days in cell-free, three days in CHO: antibody sequence to data with Biointron’s RushDATA™
A few years ago, a drug discovery team could only rank a handful of candidates at a time. Today a generative model can propose several thousand sequences in hours. The design step, once the slowest part of antibody discovery, has become one of the fastest. Validation is where the calendar time now sits. Expression, binding […] The post Two days in cell-free, three days in CHO: antibody sequence…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.